1. Home
  2. CELU vs LEE Comparison

CELU vs LEE Comparison

Compare CELU & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • LEE
  • Stock Information
  • Founded
  • CELU 2016
  • LEE 1890
  • Country
  • CELU United States
  • LEE United States
  • Employees
  • CELU N/A
  • LEE N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • CELU Health Care
  • LEE Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • LEE Nasdaq
  • Market Cap
  • CELU 42.2M
  • LEE 42.1M
  • IPO Year
  • CELU N/A
  • LEE N/A
  • Fundamental
  • Price
  • CELU $3.86
  • LEE $4.34
  • Analyst Decision
  • CELU Buy
  • LEE
  • Analyst Count
  • CELU 1
  • LEE 0
  • Target Price
  • CELU $6.00
  • LEE N/A
  • AVG Volume (30 Days)
  • CELU 66.2K
  • LEE 31.2K
  • Earning Date
  • CELU 10-15-2025
  • LEE 08-07-2025
  • Dividend Yield
  • CELU N/A
  • LEE N/A
  • EPS Growth
  • CELU N/A
  • LEE N/A
  • EPS
  • CELU N/A
  • LEE N/A
  • Revenue
  • CELU $44,590,000.00
  • LEE $581,809,000.00
  • Revenue This Year
  • CELU $23.29
  • LEE N/A
  • Revenue Next Year
  • CELU N/A
  • LEE N/A
  • P/E Ratio
  • CELU N/A
  • LEE N/A
  • Revenue Growth
  • CELU 138.11
  • LEE N/A
  • 52 Week Low
  • CELU $1.00
  • LEE $3.79
  • 52 Week High
  • CELU $5.22
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • CELU 60.90
  • LEE 42.55
  • Support Level
  • CELU $3.52
  • LEE $4.20
  • Resistance Level
  • CELU $4.01
  • LEE $4.50
  • Average True Range (ATR)
  • CELU 0.34
  • LEE 0.34
  • MACD
  • CELU -0.01
  • LEE 0.09
  • Stochastic Oscillator
  • CELU 64.84
  • LEE 63.37

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: